Tom Zhang
Memorial Sloan Kettering Cancer Center
ORCID: 0009-0007-0979-9719Also affiliated with New York Medical College, Kettering University
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 4 papers. Top paper: “Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations”.
Igor Odintsov, Keiji Ishida, Allan J.W. Lui, Masanori Kato, Tatsuya Suzuki +28 more
Maisam Makarem, Mizuki Nishino, S. Emily Bachert, Tom Zhang, Jaclyn LoPiccolo +11 more
Christopher A. Febres‐Aldana, Zebing Liu, Jenna-Marie Dix, Ryan Cheng, Raymond G. Dematteo +13 more
Tom Zhang, Ryan R. Cheng, Marissa S. Mattar, Juan Luis Gomez Marti, Leo Gili +12 more